Education
About Us
Working with TipRanks
Follow Us
Bain Capital Life Sciences Investors, LLC Insider Profile
4 Followers
Bain Capital Life Sciences Investors, LLC, Ten Percent Owner at Dicerna Pharma, holds 12.45M shares in HeartFlow, Inc. (Ticker: HTFL), holds 4.30M shares in Olema Pharmaceuticals (Ticker: OLMA), holds 3.16M shares in Kyverna Therapeutics, Inc. (Ticker: KYTX). Most recently, Bain Capital Life Sciences Investors, LLC Bought ― shares of HeartFlow, Inc. on Aug 13, 2025 for an estimated value of $6.60M.
Bain Capital Life Sciences Investors, LLC Dicerna Pharma (DRNA)Ten Percent Owner
Dicerna Pharma (DRNA)
Ten Percent Owner
Ranked #26,663 out of 102,971 Corporate Insiders
Profitable Transactions
9 out of 16 Profitable Transactions
Average Return
+3.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of Bain Capital Life Sciences Investors, LLC's holdings
Insider Roles
Roles that Bain Capital Life Sciences Investors, LLC holds in companies
Most Profitable Insider Trade
Stock:
Springworks Therapeutics
(SWTX)
(SWTX)
Rating:Informative Buy
Date:Sep 19, 2019 - Sep 19, 2020
Return:+96.70%
The most profitable trade made by Bain Capital Life Sciences Investors, LLC
Bain Capital Life Sciences Investors, LLC's Trading History
Dicerna Pharma
Nov 21, 2019
―
Informative Sell
38.55M
$213.28M
Marinus
Dec 19, 2017
―
Informative Sell
10.02M
$2.19M
Replimune Group
Jul 26, 2018
Ten Percent Owner
Uninformative Buy
―
$15.19M
Springworks Therapeutics
Aug 12, 2021
―
Informative Sell
70.25M
$227.08M
Arcutis Biotherapeutics
Feb 06, 2020
Ten Percent Owner
Uninformative Buy
―
$63.59M
Annexon Biosciences
May 30, 2023
Ten Percent Owner
Informative Buy
639.00K
$13.57M
Aptinyx
Oct 27, 2020
―
Informative Buy
10.00M
$853.61K
Rapid Micro Biosystems
Jul 21, 2021
Ten Percent Owner
Uninformative Buy
―
$23.79M
Xilio Therapeutics
Dec 10, 2021
Ten Percent Owner
Informative Buy
410.07K
$1.97M
Solid Biosciences
Jan 12, 2024
Director, Ten Percent Owner
Uninformative Buy
5.00M
$24.89M
Kyverna Therapeutics, Inc.
Feb 14, 2024
Ten Percent Owner
Uninformative Buy
―
$11.20M
NewAmsterdam Pharma Company
―
Ten Percent Owner
―
―
Olema Pharmaceuticals
Jan 13, 2025
Ten Percent Owner
Informative Buy
1.73M
$22.62M
HeartFlow, Inc.
Aug 13, 2025
Ten Percent Owner
Informative Buy
6.60M
$419.38M
List of latest transactions for each holding click on a transaction to see Bain Capital Life Sciences Investors, LLC's performance on stock
You May Also Like
Bain Capital Life Sciences Investors, LLC insider profile FAQ
What is the percentage of profitable transactions made by Bain Capital Life Sciences Investors, LLC?
The percentage of profitable transactions made by Bain Capital Life Sciences Investors, LLC is 56%.
What is the average return per transaction made by Bain Capital Life Sciences Investors, LLC?
The average return per transaction made by Bain Capital Life Sciences Investors, LLC is 3.10%.
What stocks does Bain Capital Life Sciences Investors, LLC hold?
Bain Capital Life Sciences Investors, LLC holds: DRNA, MRNS, REPL, SWTX, ARQT, ANNX, APTX, RPID, XLO, SLDB, KYTX, NAMS, OLMA, HTFL stocks.
What was Bain Capital Life Sciences Investors, LLC’s latest transaction?
Bain Capital Life Sciences Investors, LLC latest transaction was an Informative Buy of $6.60M.
What was Bain Capital Life Sciences Investors, LLC's most profitable transaction?
Bain Capital Life Sciences Investors, LLC’s most profitable transaction was an Informative Buy of SWTX stock on September 19, 2019. The return on the trade was 96.70%.
What is Bain Capital Life Sciences Investors, LLC's role in Dicerna Pharma?
Bain Capital Life Sciences Investors, LLC's role in Dicerna Pharma is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.